COMP <GO>
QXO vs PG // RSI-14 & 200D SMA MOMENTUM
QXO Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: QXO 2
— PG 12
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PG
LAST: $11.04 (-2.99%) • MKT CAP: $11.81B
rsi-technicals
48.0
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QXO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QXO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.00% | 51.20% | -28.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.90% | 25.40% | -27.30 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.39% | 3.77% | -4.16 | PG | /fcf-yield <GO> |
| Operating Margin | -3.60% | 24.30% | -27.90 | PG | /operating-margins <GO> |
| Net Profit Margin | -4.10% | 19.00% | -23.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 0.30% | +179.70 | QXO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.79 | 5.59 | -3.80 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.50% | +0.10 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 48.0 | 62.7 | -14.63 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 0.87 | +0.05 | QXO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 21.7x | +9.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.81B | $372.21B | -$360.41B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QXO REV | PG REV | QXO GROSS % | PG GROSS % | QXO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.84B | $84.28B | 23.0% | 51.2% | -$46.5M | $14.04B |
| FY 2024 | $56.9M | $84.04B | 40.6% | 51.4% | $84.7M | $16.52B |
| FY 2023 | $54.5M | $82.01B | 44.0% | 44.0% | -$1.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QXO // BETA 0.92
PG // BETA 0.87